Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Myriad Genetics (MYGN) over the last 16 years, with Sep 2025 value amounting to -$27.4 million.

  • Myriad Genetics' Income from Continuing Operations fell 23.98% to -$27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$400.5 million, marking a year-over-year decrease of 245.26%. This contributed to the annual value of -$127.3 million for FY2024, which is 51.65% up from last year.
  • Myriad Genetics' Income from Continuing Operations amounted to -$27.4 million in Q3 2025, which was up 91.71% from -$330.5 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Income from Continuing Operations registered a high of $24.6 million during Q3 2021, and its lowest value of -$330.5 million during Q2 2025.
  • Over the past 3 years, Myriad Genetics' median Income from Continuing Operations value was -$36.7 million (recorded in 2024), while the average stood at -$68.1 million.
  • Per our database at Business Quant, Myriad Genetics' Income from Continuing Operations spiked by 261.84% in 2021 and then slumped by 800.54% in 2025.
  • Myriad Genetics' Income from Continuing Operations (Quarterly) stood at -$7.6 million in 2021, then plummeted by 456.58% to -$42.3 million in 2022, then climbed by 26.24% to -$31.2 million in 2023, then tumbled by 36.22% to -$42.5 million in 2024, then fell by 23.98% to -$27.4 million in 2025.
  • Its last three reported values are -$27.4 million in Q3 2025, -$330.5 million for Q2 2025, and -$100,000 during Q1 2025.